Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9MB9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,120
Award facts
- Contract value 100% obligated
- $49,120.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $49,120.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen auto-injectors on January 20, 2026, with completion scheduled for January 21, 2026. This non-set-aside delivery order was placed under AmerisourceBergen's parent company Cencora, Inc.'s comprehensive Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The contract vehicle serves as the primary pharmaceutical supply mechanism for delivering brand-name and generic medications, vaccines, and medical devices to support military healthcare programs globally, including services to military treatment facilities and the Defense Health Agency.
Dupixent (dupilumab) is a biologic treatment commonly used for moderate-to-severe atopic dermatitis, asthma, and eosinophilic conditions. As a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen maintains a significant role in the federal medical supply chain, leveraging its extensive network to fulfill critical pharmaceutical requirements across the Department of Defense healthcare system. The delivery order's tight completion timeline indicates this is a replenishment order under an existing contract vehicle rather than a new procurement, reflecting the ongoing demand for specialty pharmaceutical products within military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9MB9?
SPE2DR26F9MB9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F9MB9 worth?
The government has obligated $49,120 on SPE2DR26F9MB9.
Is contract SPE2DR26F9MB9 an order under another contract?
Yes. SPE2DR26F9MB9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MB9 competed?
The extent of competition for SPE2DR26F9MB9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award